News
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...
Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...
Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results